Home / Companies / Centessa Pharmaceuticals Plc / 20 Jun 2025
Centessa Pharmaceuticals Plc: meeting of 20 Jun 2025
Votes reported on Form N-PX, item by item
56 Form N-PX filers reported votes at the Centessa Pharmaceuticals Plc meeting of 20 Jun 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 59.2% of reported votes for; 34 filers withheld from or voted against at least one nominee.
102 vote records from 41 filers. 0 of the 41 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
25 vote records from 14 filers. 0 of the 14 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
153 vote records from 41 filers. 0 of the 41 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
102 vote records from 41 filers. 19 of the 41 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
101 vote records from 42 filers. 0 of the 42 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
49 vote records from 39 filers. 0 of the 39 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| BlackRock and iShares | Split or no vote | For | For |
| Fidelity | Split or no vote | No report | For |
| State Street and SPDR | Split or no vote | No report | For |
| American Century | Split or no vote | No report | For |
| Franklin Templeton | Split or no vote | No report | For |
| Equitable | For | No report | For |
| ProShares and ProFunds | Split or no vote | No report | For |
| John Hancock and Manulife | For | No report | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | No report | For |
| T. Rowe Price | For | No report | For |
| First Trust | Split or no vote | No report | For |
| Russell Investments | Split or no vote | No report | For |
| Brighthouse Funds | For | No report | For |
| Transamerica | For | No report | For |
| MassMutual | For | No report | For |
| Janus Henderson | Split or no vote | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Centessa Pharmaceuticals Plc meeting?
56 Form N-PX filers reported votes at the meeting of 20 Jun 2025. On say-on-pay, 0 of 14 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Centessa Pharmaceuticals Plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Centessa Pharmaceuticals Plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Centessa Pharmaceuticals Plc with a meeting date within three days of 20 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.